Synergistic utility of NBD-Cl fluorogenic loading activity and salting-out assisted liquid–liquid extraction as sample pretreatment in rasagiline tracking in different matrices

Ahmed A. Abu-hassan,Bassam Shaaban Mohammed,Wael A. Mahdi,Alshehri,Mohamed A. El Hamd,Sultan Alshehri

DOI: https://doi.org/10.1016/j.saa.2024.124168

IF: 4.831

2024-03-20

Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy

Abstract:A typical drug used to treat Parkinson's disease is called rasagiline. It belongs to an assortment of drugs known as monoamine oxidase inhibitors, which function by raising dopamine levels in the brain. This work created a unique spectrofluorimetric method for the analytical assay of rasagiline for the first time. The approach utilized the synergistic utility of the fluorogenic properties of benzofurazan and salting-out assisted liquid–liquid extraction. By combining these techniques an ultrasensitive, and highly selective methodology for the assay of rasagiline was established. Measurements were made of the resultant yellow fluorescent product at 533 nm by applying an excitation wavelength of 475.3 nm. The calibration graph was examined to assess its linearity across a range of 30–600 ng/ml. Through estimation, the limit of detection was discovered to be 8.9 ng/ml, while the quantitation limit was estimated to be 27 ng/ml. All relevant parameters influencing the fulfillment of the developed method were thoroughly examined and tuned. Following the directives set by the (ICH) the suggested approach was confirmed and demonstrated its capability for the accurate determination of rasagiline in tablets, as well as for testing content uniformity. The incorporation of salting-out assisted liquid–liquid extraction technology enables effective tracking of rasagiline in plasma samples, providing a novel and innovative approach for its analysis in biological matrices.

spectroscopy